CRNX   $54.85  3.98% Market Open

Crinetics Pharmaceuticals Inc
Total Cash 862.95M
totalCashPerShare 10.782
EBITDA -276.18M
Total Debt 53.32M
quickRatio 15.961
currentRatio 16.087
Total Revenue 1.39M
debtToEquity 6.418
Revenue/Share 0.02
ROA -0.28274
ROE -0.47662
grossProfits
freeCashflow -99.73M
operatingCashflow -178.33M
earningsGrowth
revenueGrowth -0.596
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -207.4762
profitMargins 0.0
enterpriseValue 3.50B
forwardPE -13.755783
floatShares 74.60M
sharesOutstanding 80.04M
sharesShort 6.22M
sharesShortPriorMonth 6.12M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.07%
Short Ratio help_outline 11.62%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 10.473
Price To Book help_outline 5.11
earningsQuarterlyGrowth
netIncomeToCommon -258.54M
trailingEps -3.76%
forwardEps -3.89%
enterpriseToEbitda -12.66
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.91 3Q 2024
institutionsCount 330
lastUpdated Sept. 16, 2024, 5:46 p.m.